Bayer AG - 30d expiry - We look to Sell at 54.48 (stop at 56.11)
Daily signals are bearish.
54.50 continues to hold back the bulls.
Bespoke resistance is located at 54.50.
Preferred trade is to sell into rallies.
The bearish engulfing candle on the daily chart is negative for sentiment.
Our profit targets will be 50.41 and 49.41
Resistance: 52.00 / 53.20...
Bayer stock is a life science company trading on the German stock exchanges with the symbol BAYN. The Company’s segments are Pharmaceuticals, Consumer Health, Crop Science and Animal Health. The Pharmaceuticals segment focuses on researching, developing and marketing prescription products and speciality therapeutics, especially in the areas of cardiology,...
Bayer has reached the longterm goal to the downside. This one could now get interesting for value investor with a longer time horizen. However it should be observed weather a stabilization is happening.
Bayer have just taken over Monsanto. This is huge as it brings together two of the biggest pharmaceutical firms globally. Looking technically, I can see some severe upside where investors look to pile into this now global powerhouse (takeover valued at $68bn). I would expect a rally to $112 based off of current market structure and the bullish harami pattern. I...
Bayer AG
Short Term
We look to Buy at 56.39 (stop at 54.46)
Trading within a Bullish Channel formation. The medium term bias is for higher levels but intraday signals are mixed. Previous support located at 56.00. Bullish divergence can be seen on the daily (the chart makes a lower low while the oscillator makes a higher low), often a signal of exhausted...
Bayer AG is a German multinational pharmaceutical and life sciences company founded in 1863. The company is headquartered in Leverkusen, Germany, and employs over 100,000 people worldwide. Bayer's core business areas are human and veterinary pharmaceuticals, consumer healthcare products, agricultural chemicals, and biotechnology products.
Bayer stock is a great...
Bayer AG is still in a correction phase since April 2015.
An important support line is at EUR 44.10. This line must hodl!
Should this be broken on a weekly or even monthly basis with a closing price below it, the range of approx. 38 Euro would be the next support zone.
A closing below 38 Euro, a down move to 20-22 Euroarea would not surprise.
At 21.62 Euro,...
After Bayer's stock recently tried to break through the support level of €39.91, it has now made another attempt. Whether the stock succeeds in sustainably breaking below this support level - as envisaged in our primary scenario - or whether it needs further impetus in the form of a corrective upward move is irrelevant for the further course of our expectations....
Hey guys, here is an analysis for Bayer.
Bayer is a global company which act in healthcare and agriculture sectors with huge profit and this sector is good to invest, BUT.
Here could come time for SHORT our positions. This is a short term trade, because from long term i guess this company will grow and create value.
If we look at the chart, we can see value...
In a strategic move to tackle its mounting debt and enhance financial flexibility, Bayer ( OTC:BAYRY ), the German pharmaceutical giant, has announced a significant shift in its dividend policy. The decision, though met with mixed reactions from investors and analysts, underscores the company's commitment to addressing its pressing financial challenges.
Facing...
